UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
A telescope’s powerful new tool may offer a better way to predict solar storms
The Daniel K. Inouye telescope snapped a clear image of sunspots.
Warren Buffett announces his retirement and warns the trade war will hurt America
The billionaire investor, now 94, also said he would be resigning as CEO at the end of the year. He spoke at Berkshire Hathaway's annual shareholder meeting known as "Woodstock for Capitalists."
Army Black Hawk helicopter forces two jetliners to abort landings at DCA
Transportation Secretary Sean Duffy says he will ask Defense Department officials why an Army Black Hawk helicopter violated flight restrictions at Ronald Reagan Washington National Airport.
Opinion: Curse other drivers? So do the pros — but they get fined
Formula 1 racing has a ban on cursing, with fines starting at about 46 thousand dollars. NPR's Scott Simon explains why drivers are darn unhappy with that.
I do think we should be having more TV weddings
As we enter wedding season, culture critic Linda Holmes suggests that we bring back the splashy TV wedding at full power.
Australia’s Prime Minister Anthony Albanese heads to a second 3-year term
Prime Minister Anthony Albanese will become the first Australian prime minister to win a second consecutive three-year term in 21 years. Opposition leader Peter Dutton conceded defeat.
